DOBI Aims To Be $100 Mil. Firm Within A Year Of ComfortScan Launch
This article was originally published in The Gray Sheet
Executive Summary
DOBI Medical Systems hopes to gain FDA approval in the third quarter of 2002 for its ComfortScan dynamic breast imaging system based on an ongoing, 10-center, 1,200 patient U.S. pivotal trial of the system for use as an adjunct to mammography
You may also be interested in...
Gen-Probe Spin-Off Planned To Avoid Chugai/Roche Diagnostic Overlap
Chugai's decision to spin off its wholly-owned diagnostic subsidiary Gen-Probe following a merger with Roche's Japanese unit, Nippon Roche, will preserve worldwide competition between Roche's Cobas AmpliScreen nucleic acid test (NAT) line and Chiron's Procleix NAT, developed with Gen-Probe
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.